-
Featured
Youth In Recovery Express Internalized Stigma and Resilience
Massachusetts General Hospital researchers found many adolescents in recovery experience internalized stigma and endorse stigmatized attitudes toward people who use alcohol and other drugs. These youth need safe places to disclose their status to people who understand their experience and will support their sobriety.
-
Insights on Substance Use Disorder Treatment and Stigma Reduction: Q&A With Sarah Wakeman, MD
Sarah E. Wakeman, MD, specializes in Substance Use Disorder (SUD) treatment and is dedicated to advancing care through integration, education, and policy advocacy. She discusses the evolving understanding of SUD, the importance of reducing stigma, and innovative approaches to integrating addiction care.
-
Case Report: Longitudinal Imaging in a Patient With Opioid-associated Amnestic Syndrome
Massachusetts General Hospital researchers believe opioid-associated amnestic syndrome deserves study as a reversible metabolic injury, based on initial findings from magnetic resonance spectroscopy and follow-up with MRI and tau positron emission tomography more than four years after antioxidant treatment.
-
Injection Drug Use Tied to Substantially Increased Risk of Periprosthetic Joint Infection
Hany Bedair, MD, Kyle Alpaugh, MD, Christopher Melnic, MD, and colleagues determined injection drug use is a significant risk factor for periprosthetic joint infection after total joint arthroplasty, finding in the largest study to date that the odds are increased more than nine-fold compared with a matched cohort.
-
Find Your Champion: Treating Patients Diagnosed With Cancer and Substance Use Disorder
Throughout the last decade of her career, Helen Shih, MD, has pursued solutions to the addiction crisis and sought to better understand the struggles of patients diagnosed with cancer and substance use disorder. Learn more in this Q&A.
-
Substance Use Disorder Increases Liver Disease Risk in Patients With Alcohol Use Disorder
Researchers at the Massachusetts General Hospital Alcohol Liver Center found that substance use disorder, especially opioid use disorder, is a key modifiable risk factor for alcohol-associated liver disease in patients with alcohol use disorder.
Addiction and Recovery Contributors
-
Amy M. Yule, MD
Medical Director, Addiction Recovery Management Service, Instructor, Harvard Medical School
Recent Article
Treatment for Substance Use Disorder Reduces Risk of Overdose in Young Adults
-
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Recent Article
Pain Catastrophizing Is Associated With Reduced Neural Response to Monetary Reward
-
Joseph Biederman, MD
Former Chief, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Former Director, Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders, Massachusetts General Hospital
Recent Article
Children of Parents With ADHD Are at Substantial Risk of Developing ADHD and Associated Impairments
-
Thomas J. Spencer, MD
Assistant Director, Pediatric Psychopharmacology Unit
Recent Article
Concurrent Use of Naltrexone May Mitigate Abuse Potential of Stimulants
-
Timothy Wilens, MD
Chief, Division of Child and Adolescent Psychiatry, Massachusetts General Hospital, Co-director, Center for Addiction Medicine, Director, Substance Abuse Services in Pediatric Psychopharmacology
Recent Article
Treatment for Substance Use Disorder Reduces Risk of Overdose in Young Adults
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.